A cross-overtrialisbeinq plannedtocomparetheefficacy of two druas inthetreatmentofrheumatoid
arthritis.
Which oneofthefollowingdesign considerations should you adopt?
washout period.wherethepatient receives placebo.should take place betweenthe
administrationofthetwvotreatments
feitherdrugisthoughttobeadisease-modifier. plans to runacross-over trialshould be
abandoned
Onlypatientswho wilguaranteetocomplete bothtreatments should berecruited
Thedesign shouldbesimplified by avoiding randomisation as patientsreceive both treatments
Thereshouldbearun-inperiod whenthepatient receives aplacebo
@1MINNDOCRINE
